Israel Englander Galectin Therapeutics Inc Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Millennium Management LLC holds 25,081 shares of GALT stock, worth $56,683. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,081

Previous 27,751 9.62%

Holding current value

$56,683

Previous $46,000 28.26%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.6 - $2.44 $4,272 - $6,514	-2,670 Reduced 9.62%	25,081 $59,000
Q4 2023 Feb 14, 2024	SELL	$1.6 - $2.18 $177,124 - $241,332	-110,703 Reduced 79.96%	27,751 $46,000
Q2 2023 Aug 14, 2023	BUY	$1.32 - $2.08 $8,818 - $13,896	6,681 Added 5.07%	138,454 $199,000
Q1 2023 May 15, 2023	SELL	$1.1 - $2.4 $142,046 - $309,919	-129,133 Reduced 49.49%	131,773 $277,000
Q4 2022 Feb 14, 2023	BUY	$1.03 - $1.36 $19,527 - $25,784	18,959 Added 7.84%	260,906 $295,000

Q3 2022 Nov 14, 2022	SELL	$1.31 - $2.48 $21,714 - $41,108	-16,576 Reduced 6.41%	241,947 $394,000
Q2 2022 Aug 15, 2022	SELL	$1.19 - $1.74 $94,521 - $138,208	-79,430 Reduced 23.5%	258,523 $339,000
Q1 2022 May 16, 2022	SELL	$1.61 - $2.31 $108,913 - $156,266	-67,648 Reduced 16.68%	337,953 $544,000
Q4 2021 Feb 14, 2022	BUY	$2.07 - $3.8 $114,398 - $210,007	55,265 Added 15.77%	405,601 $840,000
Q3 2021 Nov 15, 2021	SELL	$2.59 - $4.15 $565,536 - $906,169	-218,354 Reduced 38.4%	350,336 $1.36 Million
Q2 2021 Aug 16, 2021	BUY	$2.07 - $5.1 $1.18 Million - $2.9 Million	568,690 New	568,690 $1.82 Million
Q4 2019 Feb 14, 2020	SELL	$2.79 - $4.32 $28,349 - $43,895	-10,161 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$3.0 - $4.05 $5,352 - $7,225	-1,784 Reduced 14.94%	10,161 $37,000
Q2 2019 Aug 15, 2019	SELL	$3.61 - $5.0 $1.27 Million - $1.76 Million	-351,527 Reduced 96.71%	11,945 $50,000
Q1 2019 May 14, 2019	BUY	$3.86 - $6.02 $1.4 Million - $2.19 Million	363,472 New	363,472 $1.86 Million
Q4 2018 Feb 14, 2019	SELL	$3.43 - $5.74 $385,528 - $645,170	-112,399 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.68 - $6.93 $77,158 - $145,301	20,967 Added 22.93%	112,399 $676,000
Q2 2018 Aug 14, 2018	SELL	$3.16 - $9.16 $13,739 - $39,827	-4,348 Reduced 4.54%	91,432 $582,000
Q1 2018 May 15, 2018	BUY	$3.78 - $5.97 $362,048 - $571,806	95,780 New	95,780 $454,000

Others Institutions Holding GALT

# of Institutions

Shares Held

7.62M

Call Options Held

61.2K

Put Options Held

View Full List

About GALECTIN THERAPEUTICS INC

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $134M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

More about GALT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account